Advertisement

Topics

Chrono CEO Alan Levy Retires, David Happel Named New Chief Executive

11:52 EST 16 Feb 2018 | Xconomy

Alan Levy, CEO and chairman of Chrono Therapeutics, is retiring. The Hayward, CA, company said Levy will remain on the board of directors. David Happel has been appointed CEO, and current board member James Young will take on the role of board chairman. Happel comes to Chrono from Horizon Pharma (NASDAQ: HZNP), where he was […]

Original Article: Chrono CEO Alan Levy Retires, David Happel Named New Chief Executive

NEXT ARTICLE

More From BioPortfolio on "Chrono CEO Alan Levy Retires, David Happel Named New Chief Executive"

Advertisement
Quick Search
Advertisement
Advertisement